Recombinant SARS-CoV Spike Protein S1 (14-680) was expressed in CHO cells using a C-terminal His tag.
|
SARS1-G241H |
|
|
10 ug
20 ug
50 ug
100 ug
|
|
|
$ 190 |
|
Overview:
The severe acute respiratory syndrome related novel coronavirus (SARS-CoV) has caused the 2002-2003 SARS epidemic that broke out in southern China, which spread to other regions of Asia, Europe and North America (1). The spike glycoprotein (S) of coronavirus belongs to the type I transmembrane protein containing two subunits, S1 and S2 (2), which is also known to be the key component to bind with host cells through the interaction with angiotensin-converting enzyme 2 (ACE2). SARS-CoV can specifically recognize ACE2 through its receptor binding domain (RBD) of S1 to initiate viral infection in humans (3).
Genebank Number:
References:
1. Li F, et al: Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Research. 2013, 100 (1): 246-254.
2. Xiao X, et al: The SARS-CoV S glycoprotein. Cell Mol Life Sci. 2004, 61 (19-20): 2428-30.
3. Wan Y, et al: Receptor recognition by the novel coronavirus from Wuhan: An analysis Bbsed on decade-long structural studies of SARS coronavirus. Journal of virology. 2020: 94.
There are no related publications available for this product.
Acute Respiratory Distress Syndrome , Cardiovascular Disease, Cell Cycle, Cellular Stress, COVID19, Gastrointestinal Diseases , Infectious Diseases , Inflammation, Lung Diseases , severe acute respiratory syndrome coronavirus 2 , Virology
SARS-CoV Spike Protein S1, Fc Tag, SARS1-G241F